Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. dominated the market today, gaining €1.54 (3.430%).
With 63 Buy predictions and 1 Sell predictions Ionis Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 79 € shows a very positive potential of 66.88% compared to the current price of 47.34 € for Ionis Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Ionis Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 3.430% | -3.859% | -33.790% | 27.258% | -30.341% | 31.463% | 48.634% |
| Ligand Pharmaceuticals | -0.800% | -3.053% | -9.286% | 120.870% | 53.012% | 316.393% | 164.970% |
| United Therapeutics | 0.290% | -3.340% | -7.866% | 76.129% | 4.985% | 111.804% | 193.203% |
| Novocure Ltd | 6.140% | -11.122% | -11.506% | 35.904% | 17.380% | -49.981% | -89.403% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by JPMorgan Chase & Co. from $72.00 to $76.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by Wells Fargo & Company from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by HC Wainwright from $125.00 to $115.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat